Niquette Hunt, CEO, has over twenty-five years’ experience in developing, launching and commercializing 20+ products across multiple verticals in the consumer medicine market. Every business she managed increased sales, profits and/or market share. Before founding Candesant, Ms. Hunt charted the commercial strategy at Revance Therapeutics and helped raise over $250 million in the 2014 IPO and follow-on financing.